The Valley Fever Center for Excellence (VFCE) at the University of Arizona College of Medicine – Tucson has been awarded a four-year, $4.8 million grant for research to speed development…
Researchers led by Arizona State University (ASU) and the Translational Genomics Research Institute (TGen) have identified altered expression of a gene called ANK1, which only recently has been associated with memory…
DxNA LLC, a molecular diagnostics company, today announced the 510(k) submission to the U.S. Food and Drug Administration (FDA) of its molecular diagnostics assay using its proprietary GeneSTAT System and GeneSTAT…
Arizona’s technology community and the Bioscience Roadmap have become driving forces behind the economic success of our state. The industry plays a significant role in almost every sector of the…
Cryptococcus, a type of fungi found worldwide that is responsible annually for upwards of 625,000 deaths, was likely originally spread across the globe in conjunction with continental drift, according to…
On May 12, 2017, Gov. Doug Ducey signed Arizona’s $9.8 billion 2018-2019 budget which provides bonding authority for $1 billion for investments in University Research Infrastructure. This investment continues a…
Dr. Daniel Von Hoff Distinguished Professor, Physician-In-Chief, and Director of Molecular Medicine at the Translational Genomics Research Institute (TGen) will receive a gold medal for excellence in clinical medicine from…
Researchers at Banner Sun Health Research Institute and Mayo Clinic are continuing to study how to diagnose early Parkinson’s disease. The research team’s most recent article titled, “Peripheral Synucleinopathy in…
At 11:01 p.m. on Thursday May 4, 2017, the Arizona Senate passed HB 2547: university infrastructure capital financing; appropriations paving the way for up to $1 billion in bonds to expand…
Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma…
Axolotl Biologix today announced that it has begun shipping its second amniotic allograft product, AxoBioMembrane™, to meet a wide range of wound care needs. Axolotl Biologix, an innovator in regenerative…
Why are some people barely affected by Valley fever while others are admitted to intensive care? The search for answers to those questions is on, thanks to a $2.27 million…
